Our Expert in Switzerland
No results available
Convertible notes switzerland has become one of the most-searched early-stage financing topics as Swiss venture capital momentum carries into 2026, yet founders and investors still struggle to find precise, practitioner-level guidance on how these instruments actually work under Swiss company law. This guide sets out the legal characterisation of SAFEs and convertible notes, the board and shareholder approvals required to convert them into shares, the drafting levers that matter in negotiation, and the tax and cap-table pitfalls that catch even experienced teams. It is written for startup founders, angel and seed investors, and in-house or corporate counsel evaluating or negotiating these instruments in Switzerland this year.
Every legal statement is anchored to Swiss primary sources, and model clauses are flagged as templates rather than legal advice. Read it as a working roadmap, not a substitute for tailored counsel on your specific deal.
Swiss venture capital inflows have remained strong into 2026, reported investment in Swiss startups rose materially in 2025, and with that momentum comes wider use of speed-friendly instruments such as SAFEs and convertible notes at the pre-seed and seed stage. The appeal is obvious: these instruments defer the difficult valuation conversation, reduce documentation, and let a company raise money quickly without a full priced round. But convenience at signing does not remove the company-law reality that conversion into shares will, at some point, engage the mechanics of the Swiss Code of Obligations governing share capital, capital increases and shareholder pre-emptive (subscription) rights.
The practical recommendation running through this guide is straightforward. Treat the convertible instrument as the beginning of a share-issuance process, not the end of a financing. Plan the governance path, capital band (formerly authorised capital) or conditional capital, board resolutions, shareholder resolutions and commercial register filings, at the time you sign, not when the conversion trigger fires. Doing so avoids the most common failures in convertible notes switzerland deals: ambiguous conversion mechanics, missing capital headroom, uncleared subscription rights, and tax surprises for the note holders. The sections below break each of these down. Note that the revised Swiss company law, in force since 1 January 2023, replaced the former “authorised capital” mechanism with a more flexible “capital band” (Kapitalband).
Because the vocabulary is imported largely from US practice, terminology causes confusion in Swiss deals. Clarity here prevents drafting errors later.
A SAFE (Simple Agreement for Future Equity) is a contract under which an investor pays money now in exchange for the right to receive shares in a future financing round, usually at a discount or subject to a valuation cap. A SAFE is not a loan: there is typically no interest, no maturity date, and no obligation to repay in cash. Under Swiss law a SAFE is a contractual arrangement creating a contingent right to future equity, it does not itself create shares. When the conversion event occurs, shares must still be issued through a formal capital increase or through pre-existing conditional capital or a capital band under the Swiss Code of Obligations.
A convertible note (in Switzerland usually documented as a convertible loan agreement) is a loan that the investor advances to the company, typically bearing interest and carrying a maturity date, which converts into equity on a defined trigger rather than being repaid in cash. It is a debt instrument until conversion. This debt characterisation drives several practical consequences: interest accrues, the loan ranks in the company’s liabilities, subordination may be needed to protect the balance sheet, and the tax treatment differs from a pure equity instrument. The convertible loan agreement switzerland format is the more familiar and more widely used vehicle among Swiss counsel, precisely because it fits cleanly within Code of Obligations loan and share-issuance concepts.
The single most important legal question is how the instrument is characterised: as debt, as an equity-linked contract, or as a security. Characterisation determines the approvals required, the accounting treatment, the tax profile and, occasionally, whether financial-market regulation applies.
A convertible loan is debt from advance until conversion. It appears as a liability, interest accrues, and if the qualifying financing never occurs the holder may have a repayment claim at maturity. Under the Swiss Code of Obligations, the loan sits within ordinary contract and obligations law until the conversion mechanism operates. A SAFE, by contrast, is generally not structured as a repayable loan; it is a contingent equity right. That distinction matters because a debt instrument requires attention to balance-sheet effects and possible subordination, whereas a non-repayable SAFE does not create a repayment liability but still requires a future share issuance to deliver the promised equity.
In both cases, the key Swiss-law point is the same: neither instrument automatically creates shares. Delivering equity on conversion requires a formal share-issuance step under the Code of Obligations, a capital increase resolved by shareholders, or the use of previously created conditional capital or a capital band. Contract drafting cannot substitute for the corporate-law act of issuing shares.
Most bilateral convertible notes and SAFEs entered into with a limited number of identified investors are not treated as publicly offered securities. However, where an instrument is designed to be transferable, standardised and capable of being traded, it may fall within the scope of financial-market regulation, potentially engaging securities or prospectus considerations under the Financial Services Act (FinSA) and the supervision of FINMA. Founders raising from a wide pool, or issuing standardised transferable instruments, should check the regulatory perimeter with reference to FINMA and FinSA guidance before proceeding. For most seed-stage convertible notes switzerland deals with a handful of known investors, this is a flag to confirm rather than a live obstacle, but it must be confirmed, not assumed.
This is where the practical work lies. A convertible instrument is easy to sign and difficult to execute if the governance path was not planned. Under Swiss company law, issuing new shares to a converting investor is a corporate act that typically requires shareholder involvement, unless the company has already created the capital headroom in advance.
The cleanest way to avoid an ad hoc shareholder meeting at each conversion is to create conditional capital or a capital band in advance. Conditional capital, in particular, is well suited to convertible instruments: shareholders resolve at a general meeting to create a pool of conditional capital that supports share issuance when defined conversion or option rights are exercised. The Swiss Code of Obligations governs the creation, limits and formalities of these capital mechanisms. When conditional capital exists and the conversion falls within its terms, shares can be issued to the converting holder without convening a fresh shareholder meeting to resolve a separate capital increase, a decisive advantage for speed and certainty.
A capital band gives the board a mandate, granted by shareholders for a defined period (up to five years) and within a defined range, to increase or reduce share capital. It provides flexibility but is time-limited and bounded by statutory limits. For recurring convertible conversions, conditional capital is usually the better structural fit; a capital band is often used alongside it for priced rounds and other equity issuances.
If no capital band or conditional capital exists at the time of conversion, the company must convene a shareholders’ meeting to resolve an ordinary capital increase to issue the new shares. This engages the full share-issuance procedure under the Code of Obligations. It also engages shareholder subscription (pre-emptive) rights: existing shareholders generally have a statutory right to subscribe for new shares in proportion to their holdings, and that right must be validly limited or withdrawn, for example through the terms of the conditional capital or capital band, or by a qualified shareholder resolution supported by good cause, before shares can be issued to a converting investor.
Failure to clear subscription rights is one of the most damaging and avoidable errors in a conversion.
Statutory amendments, changes to the articles of association to reflect a new share-capital figure or the creation of capital pools, likewise require shareholder resolutions, generally with the relevant qualified majority and in publicly notarised form. The board alone cannot amend the articles.
Whether the path runs through pre-existing conditional capital or a fresh capital increase, the board must document its resolutions carefully. Prepare and retain a document set covering the convertible instrument, the conversion notice, the board resolution acknowledging or effecting the issuance, the shareholder resolutions where required, the amended articles, and the commercial register filing. A working checklist:
Because shareholder meetings and resolutions carry procedural formality, and many steps require notarisation and commercial register registration, counsel and a notary should manage the mechanics.
Good drafting turns a convertible instrument from a source of disputes into a predictable financing tool. The clauses below are the ones that repay careful attention.
Define precisely when and how conversion happens. The three common models are automatic conversion (on a qualified financing above a defined threshold), voluntary conversion (at the holder’s election, often at maturity), and conversion at the next financing regardless of size. Specify the qualifying-financing threshold, the shares into which conversion occurs, the price-per-share formula, and what happens at maturity if no qualifying round arrives. Ambiguity here is the single most litigated feature of convertible instruments, so leave nothing to inference.
The valuation cap discount switzerland negotiation is the economic heart of the deal. A valuation cap sets a ceiling on the valuation used to price conversion; a discount gives a percentage reduction to the next-round price; some deals apply the more favourable of the two, some apply both. Whichever mechanism is chosen, express it as an unambiguous formula with defined inputs and a stated rounding convention. State clearly whether the cap applies to pre-money or post-money valuation, because that single choice materially changes the number of shares the investor receives.
For a convertible loan, define the maturity date, the interest rate, and whether accrued interest converts into equity or is paid. Address what happens if the company cannot convert and cannot repay: is the loan extended, does it become payable, does it convert at a default valuation? Set out the repayment waterfall in an insolvency or sale scenario so the parties know their priority.
Convertible loans are frequently subordinated so they do not distort the balance sheet or block future senior financing. Whether to grant security, and whether to subordinate to other creditors, is a negotiation between investor protection and the company’s future funding flexibility. Seed investors often accept unsecured, subordinated positions in exchange for cap and discount economics; later or larger notes may seek security.
Some convertible instruments include anti-dilution protection so that a subsequent down-round does not disproportionately dilute the early investor. These provisions are complex and can deter follow-on investors, so use them deliberately. In a seed-stage safe agreement switzerland or convertible note, the valuation cap already provides substantial downside protection, and layering formal anti-dilution ratchets on top is often unnecessary and counterproductive.
All clause wording should be treated as a starting draft, annotated with the relevant Code of Obligations references, and reviewed by qualified counsel before use. Template language accelerates drafting; it does not replace legal review.
Understanding cap table dilution from a convertible note before signing prevents unpleasant surprises at conversion. The mechanics of a valuation cap and discount mean the effective conversion price, and therefore the shares issued and the dilution, can differ substantially from the headline round price.
Consider a simplified, illustrative example. A startup raises CHF 500,000 on a convertible note with a CHF 5 million post-money valuation cap and a 20 percent discount. Twelve months later it closes a priced Series A at a CHF 10 million pre-money valuation, with a share price of CHF 10 per share.
Had the note converted at the full round price of CHF 10, the investor would have received only 50,000 shares. The cap therefore doubles the investor’s share count and correspondingly increases founder dilution. The table below illustrates the difference. These figures are simplified and ignore fully diluted share-count effects, rounding conventions and accrued interest, which materially affect real deals.
| Conversion basis | Price per share | Shares to note holder (CHF 500k) | Relative dilution effect |
|---|---|---|---|
| Round price (no cap/discount) | CHF 10.00 | 50,000 | Lowest founder dilution |
| Discount only (20%) | CHF 8.00 | 62,500 | Moderate |
| Valuation cap applied | CHF 5.00 | 100,000 | Highest founder dilution |
The lesson: founders should model conversion at plausible future valuations before agreeing a cap, and investors should confirm which mechanism governs where cap and discount both apply. Small drafting choices, pre-money versus post-money cap, whether interest converts, move these numbers materially.
Tax treatment turns on the debt-versus-equity characterisation of the instrument. A convertible loan is generally a liability in the company’s accounts until conversion, with interest treated accordingly; on conversion, the debt is typically extinguished against the issuance of equity. The company-level treatment of a straightforward conversion is often broadly neutral, but the position for the holder can differ, and specific facts, including any discount or below-market conversion terms, may raise income or capital gains questions for the investor. Swiss issuance stamp duty (Emissionsabgabe) on newly issued equity, subject to available exemptions and thresholds set by the Swiss Federal Tax Administration, and possible withholding tax considerations on interest, can also arise depending on structure.
Because the outcomes are fact-sensitive, confirm the treatment with Swiss Federal Tax Administration guidance and local tax counsel before conversion, particularly where employee participation or founder shares interact with the converting instrument. On accounting, be clear from the outset whether the instrument is presented as debt or equity, as this affects the balance sheet, covenant compliance and later diligence. On regulation, revisit the FinSA/FINMA perimeter if the instrument becomes transferable or standardised in a way that could make it a tradable security, which may engage securities or prospectus rules.
Most disputes and delays trace back to a short list of avoidable errors. Work through this checklist before signing and again before converting.
Neither instrument is universally superior; the right choice depends on stage, investor expectations and the company’s governance readiness. The table below compares the two on the dimensions that matter for Swiss startups.
| Feature | SAFE | Convertible note | Practical impact for Swiss startups |
|---|---|---|---|
| Document complexity | Lower, no debt terms | Higher, loan, interest, maturity | SAFE is faster to sign; note gives more certainty on downside |
| Governance approvals required | Share issuance still needed on conversion | Share issuance still needed on conversion | Both require a capital increase or conditional capital / capital band |
| Conversion trigger | Future financing, cap/discount driven | Financing or maturity, with repayment fallback | Note protects investor if no round occurs |
| Tax treatment | Contingent equity right | Debt until conversion; interest accrues | Note requires closer tax and accounting attention |
| Investor protections | Cap and discount only | Cap, discount, interest, maturity, possible security | Note offers stronger investor position |
| Typical stage fit | Very early pre-seed | Seed and bridge rounds | Choose by investor risk appetite and stage |
Recommendation framework: at the very earliest pre-seed stage, where speed and simplicity dominate and investors accept high risk, a SAFE-style instrument can work. For seed and bridge financings, and where investors want downside protection, the convertible loan agreement switzerland format is usually preferable and better aligned with Swiss counsel practice. In all cases, plan the conditional capital or capital band at signing so conversion is a mechanical, not a contested, event.
The snippets below are illustrative starting points only. They are templates, not legal advice, and each must be adapted and reviewed against the Swiss Code of Obligations and your articles of association before use.
Resolutions to prepare and, where required, notarise and file with the commercial register include the shareholder resolution creating conditional capital or a capital band, the board resolution effecting the share issuance, the resolution amending the articles, and the registration application evidencing the completed capital increase. Registration formalities and article amendments should be handled with counsel and a notary to ensure the filing is accepted first time.
Convertible notes switzerland deals are fast to sign but only work smoothly when the conversion path is engineered in advance. The recurring theme is planning: characterise the instrument correctly, create conditional capital or a capital band so conversion is mechanical, clear subscription rights, document board and shareholder resolutions in the right form, file with the commercial register, and confirm the tax position before conversion. Founders and investors who do this early avoid the disputes, delays and dilution surprises that catch unprepared teams.
As a practical checklist for your next deal: run due diligence on the existing cap table and articles, draft the convertible instrument with unambiguous conversion and pricing clauses, build the board and shareholder timetable, and take Swiss counsel on the governance and tax mechanics before you sign. This is general information and not legal advice; for a specific transaction, consult qualified Swiss corporate counsel through the Corporate practice, Switzerland resources and the Swiss corporate lawyers directory.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Beat Eisner at Lenz Caemmerer, a member of the Global Law Experts network.
posted 7 minutes ago
posted 10 minutes ago
posted 14 minutes ago
posted 17 minutes ago
posted 18 minutes ago
posted 23 minutes ago
posted 27 minutes ago
posted 32 minutes ago
posted 35 minutes ago
posted 42 minutes ago
posted 43 minutes ago
posted 43 minutes ago
No results available
Find the right Legal Expert for your business
Send welcome message